228 related articles for article (PubMed ID: 3604877)
1. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
[TBL] [Abstract][Full Text] [Related]
2. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
[TBL] [Abstract][Full Text] [Related]
3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
Franciosa JA; Cohn JN
Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
[TBL] [Abstract][Full Text] [Related]
5. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure.
Tisdale JE; Gheorghiade M
Am J Cardiol; 1992 Jun; 69(18):34G-47G. PubMed ID: 1626491
[TBL] [Abstract][Full Text] [Related]
7. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.
Gheorghiade M; Hall V; Lakier JB; Goldstein S
J Am Coll Cardiol; 1989 Jan; 13(1):134-42. PubMed ID: 2562844
[TBL] [Abstract][Full Text] [Related]
8. Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.
Massie BM; Kramer B; Haughom F
Circulation; 1981 Dec; 64(6):1218-26. PubMed ID: 6794935
[TBL] [Abstract][Full Text] [Related]
9. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study.
Ribner HS; Plucinski DA; Hsieh AM; Bresnahan D; Molteni A; Askenazi J; Lesch M
Am J Cardiol; 1985 Nov; 56(13):896-904. PubMed ID: 3904388
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
12. Hydralazine therapy in severe chronic heart failure: inability of radionuclide left ventricular ejection fraction measurement to predict the hemodynamic response.
Goldberg MJ; Franklin BA; Rubenfire M; Kerin NZ; Willens HJ; Ruskin R
J Am Coll Cardiol; 1983 Nov; 2(5):887-93. PubMed ID: 6313788
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Massie BM; Kramer B; Shen E; Haughom F
Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
[TBL] [Abstract][Full Text] [Related]
15. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
[TBL] [Abstract][Full Text] [Related]
16. Hydralazine in heart failure.
Chatterjee K
Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
[TBL] [Abstract][Full Text] [Related]
17. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators.
Gheorghiade M; St Clair J; St Clair C; Beller GA
J Am Coll Cardiol; 1987 Apr; 9(4):849-57. PubMed ID: 3558983
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
